Lung Cancer Markers

Only 15% of lung cancer cases are discovered while the tumor is in the early stages of development

The second most common cancer is lung cancer.  Last year in the US, nearly 220,000 people were newly diagnosed with lung cancer.  That is more than double the amount of people that fit in the Michigan Stadium.  The high number of those affected could be lowered through the use of early diagnosis techniques.

One early diagnosis technique involves the use of biomarkers.  Biomarkers are biological molecules which are used to measure the progress of disease.  They are also used to measure the effects of treatment.

Dr. Sung Baek and fellow researchers from The Institute of Drug Development study biomarkers.  They identified potential biomarkers for lung cancer and asthma.  The greater understanding of lung cancer and asthma biomarkers may greatly lower the number of lung cancer deaths.

STUDY DETAILS

STUDY: Identification of Serum Biomarkers for Lung Cancer

Researcher: Dr. Sung Baek, Dr. Elzbieta Izbicka, Dr. David Campos, Dr. Robert Streeper, and Dr. Armando Diaz III

Ask your most pressing medical and health questions at JBNI’s Team of Scientists and Physicians at http://jbni.us/forum or http://twitter.com/JBNIherbs. JBNI Genomics and Cancer Proteomics is the Maker of 100% Natural Bioprin. Bioprin is totally gentle on your stomach.

Posted via web from Mind and Body Health Myths that You Still Believe – Bioprin